Bayer (BAYRY) announced that the FDA granted 510(k) clearance for expanded capabilities of its Medrad MRXperion Magnetic Resonance Injection System, a power injector designed to support efficient workflow and consistent contrast delivery across a broad range of MR environments.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY: